MedTrace Logo

Endoscopic Pancreatic Duct Stent Placement Versus Conventional Approach in the Treatment of Early Phase Acute Pancreatitis

NCT07093996 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-07-30

No results posted yet for this study

Summary

The planned multicenter randomized study is aimed to assess the efficacy and safety of endoscopic pancreatic duct stenting in adult patients with acute pancreatitis. It is planned to include patients with early-stage nonbiliary pancreatitis in the study.

Conditions

  • Acute Pancreatitis (AP)

Interventions

PROCEDURE

Endoscopic pancreatic duct stent placement

Endoscopic pancreatic duct stent placement will be performed with a 5Fr Boston Scientific pancreatic stent (3-4 cm in length) within 24 hours from the randomization procedure. The stent will be removed on the 5th day after installation.

DRUG

Conventional treatment of acute pancreatitis in early phase

Infusion therapy, pain relief, nutritional support and surgical procedure if needed

Sponsors & Collaborators

  • Almazov National Medical Research Centre

    lead OTHER

Principal Investigators

  • Badri V Sigua, PhD · Almazov National Medical Research Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-12-01
Completion
2027-02-01

Countries

  • China
  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07093996 on ClinicalTrials.gov